NRD
ANGO icon

Nebula Research & Development’s AngioDynamics ANGO Stock Holding History

Nebula Research & Development’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,116
Closed -$140K – 58
2025
Q2 		$140K Sell
14,116
-17,329
-55% -$170K 0.01% 910
2025
Q1 		$295K Buy
31,445
+17,786
+130% +$187K 0.03% 764
2024
Q4 		$125K Buy
+13,659
New +$100K 0.01% 847
2023
Q3 		– Sell
-18,054
Closed -$188K – 483
2023
Q2 		$188K Buy
+18,054
New +$174K 0.14% 277

Other funds holding ANGO

DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nebula Research & Development's ANGO Position: Q3 2025 in Review

Nebula Research & Development sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 14,116 shares — an estimated $140K sold.

Nebula Research & Development first reported a position in ANGO in Q2 2023 and held it in 4 quarters. The position peaked at $295K in Q1 2025. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.

  • Nebula Research & Development reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 14,116 AngioDynamics shares in Q3 2025, an estimated $140K.
  • Nebula Research & Development first reported a position in AngioDynamics in Q2 2023 and held it in 4 quarters.
  • Nebula Research & Development's AngioDynamics position peaked at $295K in Q1 2025.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.